Carrow Wells

Mrs. Carrow Wells

orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 March 2013 in Nature Chemical Biology
Verified
Journal Article
Closed access
MLMercedes Lobera
Mercedes Lobera
KMKevin P Madauss
Kevin P Madauss
DPDenise T Pohlhaus
Denise T Pohlhaus
QWQuentin Wright
Quentin Wright
MTMark Trocha
Mark Trocha
MNMichael A Nolan
Michael A Nolan

2 August 2017 in PLOS ONE
Verified
Journal Article
Open access
PDF file
David DrewryDavid Drewry
David Drewry
CWCarrow Wells
Carrow Wells
DADavid Andrews
David Andrews
RARichard Angell
Richard Angell
HAHassan Al-Ali
Hassan Al-Ali
TWTimothy M Willson
Timothy M Willson
Protein kinases are highly tractable targets for drug discovery. However, the biological function and therapeutic potential of the majority of the 500+ human protein kinases remains unknown. We have developed physical and virtual collections of small molecule inhibitors, which we call chemogenomic sets, that are designed to inhibit the catalytic function of almost half the human protein kinases. In this manuscript we share our progress towards generation of a comprehensive kinase chemogenomic set (KCGS), release kinome profiling data of a large inhibitor set (Published Kinase Inhibitor Set 2 (PKIS2)), and outline a process through which the community can openly collaborate to create a KCGS that probes the full complement of human protein kinases.

2 June 2020 in Nature Communications
Verified
Journal Article
Open access
PDF file
CWCarrow Wells
Carrow Wells
JVJames D. Vasta
James D. Vasta
CCCesear R. Corona
Cesear R. Corona
JWJennifer Wilkinson
Jennifer Wilkinson
CZChad A. Zimprich
Chad A. Zimprich
MRMatthew B. Robers
Matthew B. Robers
Concerted multidisciplinary efforts have led to the development of Cyclin-Dependent Kinase inhibitors (CDKi’s) as small molecule drugs and chemical probes of intracellular CDK function. However, conflicting data has been reported on the inhibitory potency of CDKi’s and a systematic characterization of affinity and selectivity against intracellular CDKs is lacking. We have developed a panel of cell-permeable energy transfer probes to quantify target occupancy for all 21 human CDKs in live cells, and present a comprehensive evaluation of intracellular isozyme potency and selectivity for a collection of 46 clinically-advanced CDKi’s and tool molecules. We observed unexpected intracellular activity profiles for a number of CDKi’s, offering avenues for repurposing of highly potent molecules as probes for previously unreported targets. Overall, we provide a broadly applicable method for evaluating the selectivity of CDK inhibitors in living cells, and present a refined set of tool molecules to study CDK function.

25 September 2018 in Science Signaling
Verified
Journal Article
Closed access
PDF file
DFDaniel Foulkes
Daniel Foulkes
DBDominic P. Byrne
Dominic P. Byrne
WYWayland Yeung
Wayland Yeung
SSSafal Shrestha
Safal Shrestha
FBFiona P. Bailey
Fiona P. Bailey
PEPatrick Eyers
Patrick Eyers
Covalent EGFR family inhibitors bind to and induce the degradation of the pseudokinase TRIB2 to kill cancer cells.

Verified
Journal Article
Open access
PDF file
CWCarrow Wells
Carrow Wells
HAHassan Al-Ali
Hassan Al-Ali
DADavid Andrews
David Andrews
CAChristopher R. M. Asquith
Christopher R. M. Asquith
Alison Donnelly AxtmanAlison Donnelly Axtman
Alison Donnelly Axtman
David DrewryDavid Drewry
David Drewry
We describe the assembly and annotation of a chemogenomic set of protein kinase inhibitors as an open science resource for studying kinase biology. The set only includes inhibitors that show potent kinase inhibition and a narrow spectrum of activity when screened across a large panel of kinase biochemical assays. Currently, the set contains 187 inhibitors that cover 215 human kinases. The kinase chemogenomic set (KCGS), current Version 1.0, is the most highly annotated set of selective kinase inhibitors available to researchers for use in cell-based screens.

8 July 2019 in Nature Chemical Biology
Verified
Journal Article
Closed access
PDF file
JBJark Böttcher
Jark Böttcher
DDDavid Dilworth
David Dilworth
URUlrich Reiser
Ulrich Reiser
RNRalph A. Neumüller
Ralph A. Neumüller
MSMichael Schleicher
Michael Schleicher
DMDarryl B. McConnell
Darryl B. McConnell